欢迎访问《标记免疫分析与临床》官方网站!
临床研究

储存式单采自体红细胞在腹膜后肿瘤择期手术中的应用

展开
  • 解放军总医院输血科,北京,100853
孙桂香,主管技师。E-mail:1721473945@qq.com

收稿日期: 2015-01-10

  修回日期: 2015-04-01

  网络出版日期: 2015-05-29

基金资助

临床有效输血及血液风险控制技术研究与应用推广(编号:201002005)

Transfusion of Pre-stored Apheresis Autologous Red Blood Cell in Retroperitoneal Tumor Elective Surgery

Expand
  • Department of Blood Transfusion, Chinese PLA General Hospital, Beijing 100853, China

Received date: 2015-01-10

  Revised date: 2015-04-01

  Online published: 2015-05-29

摘要

目的 探讨普外科腹膜后肿瘤择期手术患者术后输注单采自体红细胞的疗效。方法 回顾性分析本院2014年1月1日至2014年11月30日20例腹膜后肿瘤择期手术患者自体输血对患者血液指标的影响及术后自体红细胞回输的疗效。结果 20例自体储血患者血常规指标单采后与单采前相比有所下降,但PLT、Hct、Hb 均维持在较高水平(PLT>150×109/L、Hct>30%、Hb>110 g/L),因此,自体储血不会造成凝血功能障碍和组织缺氧。回输自体血后患者的血液指标与术后相比有所回升,防止了术后失血性贫血的发生。结论 普外科择期手术术后输注单采自体红细胞是一种安全有效的输血方案,不仅可以解决择期大手术的输血需求,而且能减少输血不良反应。

本文引用格式

孙桂香,席朝运,李 卉,师红梅,汪德清 . 储存式单采自体红细胞在腹膜后肿瘤择期手术中的应用[J]. 标记免疫分析与临床, 2015 , 22(4) : 275 . DOI: 10.11748/bjmy.issn.1006-1703.2015.04.005

Abstract

Objective To evaluate the efficacy of the transfusion of pre-stored apheresis autologous red blood cell in retroperitoneal tumor elective surgery. Methods 20 patients in our hospital from January 1 to November 30 in 2014 who were underwent transfusion of pre-stored pheresis autologous red blood cell for retroperitoneal tumor elective surgery were retrospectively analyzed. Results The routine blood indicators of 20 patients after apheresis blood collection were decreased, but the PLT, Hct, Hb were maintained at a higher level (PLT > 150×109/L, Hct>30%, Hb>110 g/L). The autologous transfusion did not cause coagulation dysfunction and tissue hypoxia. After transfusing autologous blood,the indicators become higher than that of preoperation, which could prevent the occurrence blood loss anemia. Conclusion Pre-storage type of autologous blood transfusion is an effective and safe method .It not only can solve the requirements for big elective surgery but also can effectively reduce the adverse transfusion reactions.
文章导航

/